No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 13.825
- -0.225-1.60%
Trading May 1 10:56 ET
15.66BMarket Cap-27650P/E (TTM)
14.040High13.700Low1.96MVolume13.980Open14.050Pre Close27.08MTurnover0.17%Turnover RatioLossP/E (Static)1.13BShares14.46552wk High2.09P/B15.56BFloat Cap7.08552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM2.42%Amplitude3.107Historical Low13.812Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 104621.0 Shares on Sell Side
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings
All three major Wall Street indexes were down in late-morning trading Tuesday in the wake of higher-than-expected employment cost data and ahead of the Federal Open Market Committee's decision on rate
Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals
Alvotech (ALVO) and Teva Pharmaceuticals' (TEVA) US affiliate said Tuesday that Alvotech will manufacture a high-concentration interchangeable biosimilar to Humira for Quallent Pharmaceuticals, which
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
10:49 AM EDT, 04/30/2024 (MT Newswires) -- FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications Price: 129.77, Change: +2.89, Percent Change: +2.28
Express News | NYSE Order Imbalance 82941.0 Shares on Buy Side
Express News | NYSE Order Imbalance 120851.0 Shares on Sell Side
Comments
UPDATE May 1
MAYDAY!!!
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
🤣 hahaha, my favorite gif 🤣
🎵 Here's where the story ends
It's that little souvenir of a terrible year
Which makes my eyes feel sore
It's that little souvenir of a terrible year
Surprise, surprise, surprise 🎵
I'm going to try and get a post out. I'm really uncomfortable and sore, but there are some big moves and big news ahead.
A little Sundays to start the day
As I said, I'm fresh out of the hospital again. I've been oversleeping and much too tired 😫. I feel gu...
loading...
6
3
$Teva Pharmaceutical Industries(TEVA.US$ & alvotechpr
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
📣 FDA approves SELARSDI (Ustekinumab-Aekn), biosimilar to Stelara® 🎉
▻ approved for both adult and pedia indications (plaque psoriasis & psoriatic arthritis)
▻ developed and manuf. using same type of cells and process used for Stelara 👨🔬
▻ to be marketed in US on or after 02/21/25 🗓️
3
1
$Teva Pharmaceutical Industries(TEVA.US$ Pray Kwan Yin bless teva
gonna observe you
$Teva Pharmaceutical Industries(TEVA.US$ let's learn how to partner with a molecular catalog shall we?
The analyst from J.P. Morgan expressed that Teva has effectively addressed concerns about the investments required to develop these assets preserving margins through strategic partnerships.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Mod Tan : thanks for sharing
TinkerB3ll : Thanks @iamiam for the extensive list wondering what’s your thoughts on MSOS?
iamiamOP TinkerB3ll: I would rather have the individual companies. MSOS is a Blackrock creation with lots of swaps and derivatives, they even have bonds
its not bad if you hold it. it's just not my thing. too many swaps and derivatives for my liking.